VERU vs. NATR, FHTX, CDT, ME, ACIU, EBS, QURE, ALDX, HOWL, and PBYI
Should you be buying Veru stock or one of its competitors? The main competitors of Veru include Nature's Sunshine Products (NATR), Foghorn Therapeutics (FHTX), Conduit Pharmaceuticals (CDT), 23andMe (ME), AC Immune (ACIU), Emergent BioSolutions (EBS), uniQure (QURE), Aldeyra Therapeutics (ALDX), Werewolf Therapeutics (HOWL), and Puma Biotechnology (PBYI). These companies are all part of the "pharmaceutical preparations" industry.
Nature's Sunshine Products (NASDAQ:NATR) and Veru (NASDAQ:VERU) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk.
Nature's Sunshine Products has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Veru has a beta of -0.47, indicating that its stock price is 147% less volatile than the S&P 500.
Nature's Sunshine Products currently has a consensus price target of $24.00, suggesting a potential upside of 52.28%. Veru has a consensus price target of $3.67, suggesting a potential upside of 156.41%. Given Nature's Sunshine Products' higher possible upside, analysts plainly believe Veru is more favorable than Nature's Sunshine Products.
Nature's Sunshine Products has a net margin of 3.39% compared to Nature's Sunshine Products' net margin of -405.04%. Veru's return on equity of 12.25% beat Nature's Sunshine Products' return on equity.
79.4% of Nature's Sunshine Products shares are held by institutional investors. Comparatively, 47.2% of Veru shares are held by institutional investors. 4.9% of Nature's Sunshine Products shares are held by insiders. Comparatively, 14.2% of Veru shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Veru received 107 more outperform votes than Nature's Sunshine Products when rated by MarketBeat users. Likewise, 69.43% of users gave Veru an outperform vote while only 62.89% of users gave Nature's Sunshine Products an outperform vote.
In the previous week, Nature's Sunshine Products and Nature's Sunshine Products both had 13 articles in the media. Veru's average media sentiment score of 1.09 beat Nature's Sunshine Products' score of 0.28 indicating that Nature's Sunshine Products is being referred to more favorably in the media.
Nature's Sunshine Products has higher revenue and earnings than Veru. Veru is trading at a lower price-to-earnings ratio than Nature's Sunshine Products, indicating that it is currently the more affordable of the two stocks.
Summary
Nature's Sunshine Products beats Veru on 11 of the 17 factors compared between the two stocks.
Get Veru News Delivered to You Automatically
Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VERU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
